MedTrace Logo

Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study

NCT03774862 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2018-12-13

No results posted yet for this study

Summary

Medullary carcinoma (MC) is a rare tumor with solid growth pattern without glandular differentiation and constitute less than 1% of colorectal cancer. Lymph node positivity and distant organ metastasis were reported to be lower than other poorly differentiated adenocarcinomas. Therefore, the diagnosis of MC is pathologically important in terms of follow-up and treatment. MC is commonly localized in the right colon, has a large tumor size, and is mostly diagnosed in the T4 stage. As MC most likely have defects in DNA MMR, the correct pathological diagnosis is important for the postoperative treatment and the prognosis of the patients.

Conditions

  • Colorectal Medullary Carcinoma

Sponsors & Collaborators

  • V.K.V. American Hospital, Istanbul

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-01
Primary Completion
2017-12-31
Completion
2018-08-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03774862 on ClinicalTrials.gov